Pharmacological Treatment of Anxiety and Depression Essay

The prevalence of anxiety disorders is a major global health problem, and experts are always looking for efficient treatment solutions. When employing anxiolytic medicines to treat anxiety disorders, pharmacokinetics and pharmacodynamics are crucial considerations. The neurotransmitters in the brain that regulate mood and anxiety symptoms are impacted by these drugs, which is how they operate. While selective serotonin reuptake inhibitors (SSRIs), which can be used to treat anxiety symptoms, are another alternative, anxiolytics are the most common drugs used to treat anxiety. It is crucial to think of a specific plan of care for each patient while treating anxiety and depression, taking into account their medical history and any possible drug adverse effects (Kamusheva et al., 2020). Pharmacological Treatment of Anxiety and Depression Essay

The case study that is being presented emphasizes the difficulties in treating an older patient who has a stroke, depression, and anxiety. The patient’s symptoms were initially treated with SSRIs, but their side effects that thin the bones raised questions. Following that, the patient received the antidepressant Emsam, which is given by transdermal injection. However, the patient’s decreased tissue blood perfusion might have had an impact on this method of administration.

ORDER  HERE A PLAGIARISM-FREE PAPER HERE

Starting with a low dose of SSRIs and progressively increasing the dosage may be a realistic approach for treating anxiety and depression in the instance at hand (Clary et al., 2019). Additionally, for an elderly patient with decreased tissue blood perfusion, choosing the injectable method as opposed to the transdermal route would be a better choice. Healthcare professionals can identify a pharmaceutical regimen that is successful while limiting negative effects by customizing the treatment strategy for each patient. In general, treating anxiety and depression calls for a holistic strategy that considers a patient’s medical background, lifestyle choices, and social support networks. Pharmacological Treatment of Anxiety and Depression Essay

References

Clary, H. M. M., & Salpekar, J. A. (2019). Should adult neurologists play a role in the management of the most common psychiatric comorbidities? Practical considerations. Epilepsy & Behavior, 98, 309-313.

https://www.sciencedirect.com/science/article/pii/S1525505018306735

Kamusheva, M., Ignatova, D., Golda, A., & Skowron, A. (2020). The potential role of the pharmacist in supporting patients with depression–a literature-based point of view. Integrated Pharmacy Research and Practice, 49-63.

https://www.tandfonline.com/doi/abs/10.2147/IPRP.S239672 Pharmacological Treatment of Anxiety and Depression Essay